MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT02269319 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: MRX-I
DRUG: Linezolid

Sponsor

MicuRx